In critically ill patients without pre-existing kidney disease, both serum and urinary NGAL measured at admission can predict AKI occurrence. NGAL has also proven to be a useful biomarker in early prediction of requirement of hemodialysis so that various metabolic derangements can be corrected at the earliest, thus, decreasing mortality.